References
I. Wiesenberg-Boettcher, A. Schweizer, J. R. Green, K. Mueller, F. Maerki and J. Pfeilschifter,The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Drugs Expl. Clin. Res.XV, 501–510 (1989).
A. Schweizer and R. Brom,Differentiation of peripheral and central effects of analgesic drugs. Int. J. Tiss. React.VII, 79–83 (1985).
A. Schweizer, U. Feige, A. Fontana, K. Mueller and C. A. Dinarello,Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E 2 levels. Agents and Actions25, 246–251 (1988).
H. Juan,Mechanism of action of bradykinin-induced release of prostaglandin E. Naunyn-Schmiedeberg's Arch. Pharmacol.300, 77–85 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schweizer, A., Brom, R. & Wiesenberg-Boettcher, I. Inhibition of interleukin-1 (IL-1) enhanced pain reflexes in the rabbit by CGP 28238. Agents and Actions 32, 67–69 (1991). https://doi.org/10.1007/BF01983314
Issue Date:
DOI: https://doi.org/10.1007/BF01983314